Back to company

B Proteomics ApS: Financial statements 2025

CVR: 44269422

B Proteomics ApS (CVR 44269422) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 747,048 and a net result of DKK 212,153. Equity amounted to DKK 258,710. The solvency ratio was 55.2%. The company had 2 employees in the financial year.

Gross Profit
747,048 kr.
Profit/Loss
212,153 kr.
Equity
258,710 kr.
Total Assets
468,449 kr.
Employees
2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like B Proteomics ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2025

B Proteomics ApS publishes interim reportApr 14, 2025

B Proteomics ApS has published its interim report for the period August 30, 2023 – December 31, 2024.

Jakob Bunkenborg joins B Proteomics ApS as adm. dir.Feb 1, 2025

As of February 1, 2025, Jakob Bunkenborg is registered as adm. dir. of B Proteomics ApS.

Angela Mc Ardle steps down as adm. dir. of B Proteomics ApSFeb 1, 2025

As of February 1, 2025, Angela Mc Ardle has stepped down as adm. dir. of B Proteomics ApS.

Jakob Bunkenborg steps down as director of B Proteomics ApSJan 31, 2025

As of January 31, 2025, Jakob Bunkenborg has stepped down as director of B Proteomics ApS.

About B Proteomics ApS

B Proteomics ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jakob Bunkenborg. The company is owned by Bunkarde Holding ApS. In 2025, the company reported a gross profit of DKK 747,048 and a net result of DKK 212,153. Equity amounted to DKK 258,710.